Venous hypertension affects veins in the legs and the way blood circulates to the heart. Learn about symptoms of venous ...

In pulmonary hypertension, a combination of metabolic and mechanical dysfunction leads to irreversible vascular damage.

Considerable variability exists in the clinical presentations of pulmonary arterial hypertension (PAH). Greater understanding of the comorbidities observed in Chinese patients with PAH is urgently ...

A recent publication in the International Journal of Cardiology, Pulmonary artery denervation in pulmonary hypertension: A comprehensive meta-analysis, has shed light on the potential of pulmonary ...

The findings from this single-center retrospective study compare outcomes between 2 groups of patients living with connective ...

A recent publication in the International Journal of Cardiology, "Pulmonary artery denervation in pulmonary hypertension: A ...

Three decades of data from the Global Burden of Disease Study were analyzed for trends in global, regional, and national ...

New podcasts from advocacy organization Phaware will highlight treatment advances in pulmonary hypertension tied to ...

Winrevair (sotatercept-csrk) significantly reduced the risk of death, lung transplant, or hospitalization in people with PAH.

pulmonary hypertension (PH), sarcoidosis, and eosinophilic pneumonia. Autophagy plays a vital role in the maintenance of homeostasis and recent studies have explored the connection between autophagy ...

Department of Clinical Laboratory, Affiliated Nantong Hospital of Shanghai University (The Sixth People’s Hospital of Nantong), Nantong, Jiangsu, China Idiopathic Pulmonary Fibrosis (IPF) is a ...

Differences in clinical presentation, diagnosis, and treatment, and the potential effects on mortality, recurrent PE, and chronic thromboembolic pulmonary hypertension (CTEPH), are reviewed in the ...